Loading...

Watson, Karol E

Title(s)Professor, Medicine
SchoolCardiology
Phone310-794-7121
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    iDISCOVER: Integrated Data Science Training in CardioVascular Medicine
    NIH/NHLBI T32HL139450Apr 1, 2018 - Mar 31, 2023
    Role: Co-Principal Investigator
    A Community Effort to Translate Protein Data to Knowledge: An Integrated Platform
    NIH/NIGMS U54GM114833Sep 29, 2014 - Apr 30, 2018
    Role: Co-Principal Investigator
    MESA Family Study
    NIH/NHLBI R01HL071051Aug 1, 2003 - Jun 30, 2009
    Role: Principal Investigator
    Oxidized Phospholipids and Angiogenesis
    NIH/NHLBI K01HL070440Jul 1, 2002 - Nov 30, 2004
    Role: Principal Investigator
    15/16 Action for Health in Diabetes Extension Study Research Project
    NIH/NIDDK U01DK057219Sep 30, 1999 - Sep 29, 2011
    Role: Co-Principal Investigator
    16/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
    NIH/NIDDK U01DK048443Aug 20, 1994 - May 14, 2003
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Richter SE, Miller L, Needleman J, Uslan DZ, Bell D, Watson K, Humphries R, McKinnell JA. Risk factors for development of aminoglycoside resistance among gram-negative rods. Am J Health Syst Pharm. 2019 10 30; 76(22):1838-1847. PMID: 31665763.
      View in: PubMed
    2. Rahman O, Markl M, Balte P, Berhane H, Blanken C, Suwa K, Dashnaw S, Wieben O, Bluemke DA, Prince MR, Lima J, Michos E, Ambale-Venkatesh B, Hoffman EA, Gomes AS, Watson K, Sun Y, Carr J, Barr RG. Reproducibility and Changes in Vena Caval Blood Flow by Using 4D Flow MRI in Pulmonary Emphysema and Chronic Obstructive Pulmonary Disease (COPD): The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Substudy. Radiology. 2019 09; 292(3):585-594. PMID: 31335282.
      View in: PubMed
    3. Han JK, Yano EM, Watson KE, Ebrahimi R. Cardiovascular Care in Women Veterans. Circulation. 2019 02 19; 139(8):1102-1109. PMID: 30779640.
      View in: PubMed
    4. Caufield JH, Zhou Y, Garlid AO, Setty SP, Liem DA, Cao Q, Lee JM, Murali S, Spendlove S, Wang W, Zhang L, Sun Y, Bui A, Hermjakob H, Watson KE, Ping P. A reference set of curated biomedical data and metadata from clinical case reports. Sci Data. 2018 11 20; 5:180258. PMID: 30457569.
      View in: PubMed
    5. Goldwater D, Karlamangla A, Merkin SS, Watson K, Seeman T. Interleukin-10 as a predictor of major adverse cardiovascular events in a racially and ethnically diverse population: Multi-Ethnic Study of Atherosclerosis. Ann Epidemiol. 2019 02; 30:9-14.e1. PMID: 30249450.
      View in: PubMed
    6. Hirshfeld JW, Ferrari VA, Bengel FM, Bergersen L, Chambers CE, Einstein AJ, Eisenberg MJ, Fogel MA, Gerber TC, Haines DE, Laskey WK, Limacher MC, Nichols KJ, Pryma DA, Raff GL, Rubin GD, Smith D, Stillman AE, Thomas SA, Tsai TT, Wagner LK, Samuel Wann L, Januzzi JL, Afonso LC, Everett B, Hernandez AF, Hucker W, Jneid H, Kumbhani D, Edward Marine J, Morris PB, Piana RN, Watson KE, Wiggins BS. 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 2: Radiological Equipment Operation, Dose-Sparing Methodologies, Patient and Medical Personnel Protection. Catheter Cardiovasc Interv. 2018 08 01; 92(2):222-246. PMID: 30160001.
      View in: PubMed
    7. Hirshfeld JW, Ferrari VA, Bengel FM, Bergersen L, Chambers CE, Einstein AJ, Eisenberg MJ, Fogel MA, Gerber TC, Haines DE, Laskey WK, Limacher MC, Nichols KJ, Pryma DA, Raff GL, Rubin GD, Smith D, Stillman AE, Thomas SA, Tsai TT, Wagner LK, Samuel Wann L, Januzzi JL, Afonso LC, Everett B, Hernandez AF, Hucker W, Jneid H, Kumbhani D, Edward Marine J, Morris PB, Piana RN, Watson KE, Wiggins BS. 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness. Catheter Cardiovasc Interv. 2018 08 01; 92(2):E35-E97. PMID: 30160063.
      View in: PubMed
    8. Hirshfeld JW, Ferrari VA, Bengel FM, Bergersen L, Chambers CE, Einstein AJ, Eisenberg MJ, Fogel MA, Gerber TC, Haines DE, Laskey WK, Limacher MC, Nichols KJ, Pryma DA, Raff GL, Rubin GD, Smith D, Stillman AE, Thomas SA, Tsai TT, Wagner LK, Samuel Wann L, Januzzi JL, Afonso LC, Everett B, Hernandez AF, Hucker W, Jneid H, Kumbhani D, Edward Marine J, Morris PB, Piana RN, Watson KE, Wiggins BS. 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 1: Radiation Physics and Radiation Biology: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways Developed in Collaboration With Mended Hearts. Catheter Cardiovasc Interv. 2018 08 01; 92(2):203-221. PMID: 30160013.
      View in: PubMed
    9. Greenland P, Blaha MJ, Budoff MJ, Erbel R, Watson KE. Coronary Calcium Score and Cardiovascular Risk. J Am Coll Cardiol. 2018 07 24; 72(4):434-447. PMID: 30025580.
      View in: PubMed
    10. Budoff MJ, Young R, Burke G, Jeffrey Carr J, Detrano RC, Folsom AR, Kronmal R, Lima JAC, Liu KJ, McClelland RL, Michos E, Post WS, Shea S, Watson KE, Wong ND. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA). Eur Heart J. 2018 07 01; 39(25):2401-2408. PMID: 29688297.
      View in: PubMed
    11. Volgman AS, Palaniappan LS, Aggarwal NT, Gupta M, Khandelwal A, Krishnan AV, Lichtman JH, Mehta LS, Patel HN, Shah KS, Shah SH, Watson KE. Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association. Circulation. 2018 07 03; 138(1):e1-e34. PMID: 29794080.
      View in: PubMed
    12. Seeman T, Thomas D, Merkin SS, Moore K, Watson K, Karlamangla A. The Great Recession worsened blood pressure and blood glucose levels in American adults. Proc Natl Acad Sci U S A. 2018 03 27; 115(13):3296-3301. PMID: 29531048.
      View in: PubMed
    13. Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, Dent S, Kondapalli L, Ky B, Okwuosa T, Piña IL, Volgman AS. Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association. Circulation. 2018 02 20; 137(8):e30-e66. PMID: 29437116.
      View in: PubMed
    14. Brown AS, Watson KE. Statin Intolerance. Rev Cardiovasc Med. 2018; 19(S1):S9-S19. PMID: 30207553.
      View in: PubMed
    15. Robinson JG, Watson KE. Identifying Patients for Nonstatin Therapy. Rev Cardiovasc Med. 2018; 19(S1):S1-S8. PMID: 30207552.
      View in: PubMed
    16. Watson KE, Fonarow GC. Closing the Remaining Evidence Gap: Randomized Controlled Trial Data to Support Statin Therapy for Low-Density Lipoprotein =190 mg/dL. Circulation. 2017 11 14; 136(20):1892-1894. PMID: 29133529.
      View in: PubMed
    17. Amrock SM, Duell PB, Knickelbine T, Martin SS, O'Brien EC, Watson KE, Mitri J, Kindt I, Shrader P, Baum SJ, Hemphill LC, Ahmed CD, Andersen RL, Kullo IJ, McCann D, Larry JA, Murray MF, Fishberg R, Guyton JR, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Underberg JA, Thompson P, Duffy D, Linton MF, Shapiro MD, Moriarty PM, Knowles JW, Ahmad ZS. Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry. Atherosclerosis. 2017 Dec; 267:19-26. PMID: 29080546.
      View in: PubMed
    18. Goldberg RB, Aroda VR, Bluemke DA, Barrett-Connor E, Budoff M, Crandall JP, Dabelea D, Horton ES, Mather KJ, Orchard TJ, Schade D, Watson K, Temprosa M. Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium. Circulation. 2017 Jul 04; 136(1):52-64. PMID: 28476766.
      View in: PubMed
    19. Aaron CP, Hoffman EA, Lima JAC, Kawut SM, Bertoni AG, Vogel-Claussen J, Habibi M, Hueper K, Jacobs DR, Kalhan R, Michos ED, Post WS, Prince MR, Smith BM, Ambale-Venkatesh B, Liu CY, Zemrak F, Watson KE, Budoff M, Bluemke DA, Barr RG. Pulmonary vascular volume, impaired left ventricular filling and dyspnea: The MESA Lung Study. PLoS One. 2017; 12(4):e0176180. PMID: 28426728.
      View in: PubMed
    20. Ping P, Watson K, Han J, Bui A. Individualized Knowledge Graph: A Viable Informatics Path to Precision Medicine. Circ Res. 2017 03 31; 120(7):1078-1080. PMID: 28360346.
      View in: PubMed
    21. Zipursky RT, Press MC, Srikanthan P, Gornbein J, McClelland R, Watson K, Horwich TB. Relation of Stress Hormones (Urinary Catecholamines/Cortisol) to Coronary Artery Calcium in Men Versus Women (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol. 2017 06 15; 119(12):1963-1971. PMID: 28456316.
      View in: PubMed
    22. Wiesner P, Watson KE. Triglycerides: A reappraisal. Trends Cardiovasc Med. 2017 08; 27(6):428-432. PMID: 28438398.
      View in: PubMed
    23. Armstrong HF, Lovasi GS, Soliman EZ, Heckbert SR, Psaty BM, Austin JH, Krishnan JA, Hoffman EA, Johnson C, Budoff MJ, Watson KE, Barr RG. Lung function, percent emphysema, and QT duration: The Multi-Ethnic Study of Atherosclerosis (MESA) lung study. Respir Med. 2017 02; 123:1-7. PMID: 28137484.
      View in: PubMed
    24. Varga TV, Winters AH, Jablonski KA, Horton ES, Khare-Ranade P, Knowler WC, Marcovina SM, Renström F, Watson KE, Goldberg R, Florez JC, Pollin TI, Franks PW. Comprehensive Analysis of Established Dyslipidemia-Associated Loci in the Diabetes Prevention Program. Circ Cardiovasc Genet. 2016 Dec; 9(6):495-503. PMID: 27784733.
      View in: PubMed
    25. Watson KE, Sallam T. MY APPROACH to the Patient With Memory Loss Who Needs a Statin. Trends Cardiovasc Med. 2017 02; 27(2):158-159. PMID: 28107839.
      View in: PubMed
    26. Lau E, Watson KE, Ping P. Connecting the Dots: From Big Data to Healthy Heart. Circulation. 2016 Aug 02; 134(5):362-4. PMID: 27481999.
      View in: PubMed
    27. Kaufman JD, Adar SD, Barr RG, Budoff M, Burke GL, Curl CL, Daviglus ML, Diez Roux AV, Gassett AJ, Jacobs DR, Kronmal R, Larson TV, Navas-Acien A, Olives C, Sampson PD, Sheppard L, Siscovick DS, Stein JH, Szpiro AA, Watson KE. Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis and Air Pollution): a longitudinal cohort study. Lancet. 2016 Aug 13; 388(10045):696-704. PMID: 27233746.
      View in: PubMed
    28. Mukku RB, Fonarow GC, Watson KE, Ajijola OA, Depasquale EC, Nsair A, Baas AS, Deng MC, Yang EH. Heart Failure Therapies for End-Stage Chemotherapy-Induced Cardiomyopathy. J Card Fail. 2016 Jun; 22(6):439-48. PMID: 27109619.
      View in: PubMed
    29. Watson KE, Wiesner P. Slippery Slope of Triglycerides: They Are Associated With Risk, But in the Statin Era, Does Targeting Them Confer Benefit? Circ Cardiovasc Qual Outcomes. 2016 Mar; 9(2):97-9. PMID: 26957516.
      View in: PubMed
    30. Wickramasinghe CD, Nguyen KL, Watson KE, Vorobiof G, Yang EH. Concepts in cardio-oncology: definitions, mechanisms, diagnosis and treatment strategies of cancer therapy-induced cardiotoxicity. Future Oncol. 2016 Mar; 12(6):855-70. PMID: 26829050.
      View in: PubMed
    31. Ziaeian B, Dinkler J, Guo Y, Watson K. The 2013 ACC/AHA Cholesterol Treatment Guidelines: Applicability to Patients with Diabetes. Curr Diab Rep. 2016 Feb; 16(2):13. PMID: 26803649.
      View in: PubMed
    32. Mehta LS, Beckie TM, DeVon HA, Grines CL, Krumholz HM, Johnson MN, Lindley KJ, Vaccarino V, Wang TY, Watson KE, Wenger NK. Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association. Circulation. 2016 Mar 01; 133(9):916-47. PMID: 26811316.
      View in: PubMed
    33. McClelland RL, Jorgensen NW, Budoff M, Blaha MJ, Post WS, Kronmal RA, Bild DE, Shea S, Liu K, Watson KE, Folsom AR, Khera A, Ayers C, Mahabadi AA, Lehmann N, Jöckel KH, Moebus S, Carr JJ, Erbel R, Burke GL. 10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study). J Am Coll Cardiol. 2015 Oct 13; 66(15):1643-53. PMID: 26449133.
      View in: PubMed
    34. Christine PJ, Auchincloss AH, Bertoni AG, Carnethon MR, Sánchez BN, Moore K, Adar SD, Horwich TB, Watson KE, Diez Roux AV. Longitudinal Associations Between Neighborhood Physical and Social Environments and Incident Type 2 Diabetes Mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA). JAMA Intern Med. 2015 Aug; 175(8):1311-20. PMID: 26121402.
      View in: PubMed
    35. Stone NJ, Merz CN, Watson KE, Smith SC. Getting guidelines correct: their evidence-based recommendations for use of nonstatins added to statins and the need for follow-up lipid testing. J Am Coll Cardiol. 2015 May 12; 65(18):2051-2. PMID: 25953756.
      View in: PubMed
    36. Ebong IA, Watson KE, Goff DC, Bluemke DA, Srikanthan P, Horwich T, Bertoni AG. Association of menopause age and N-terminal pro brain natriuretic peptide: the Multi-Ethnic Study of Atherosclerosis. Menopause. 2015 May; 22(5):527-33. PMID: 25290536.
      View in: PubMed
    37. Scruggs SB, Watson K, Su AI, Hermjakob H, Yates JR, Lindsey ML, Ping P. Harnessing the heart of big data. Circ Res. 2015 Mar 27; 116(7):1115-9. PMID: 25814682.
      View in: PubMed
    38. Mitchell A, Misialek JR, Folsom AR, Duprez D, Alonso A, Jerosch-Herold M, Sanchez OA, Watson KE, Sallam T, Konety SH. Usefulness of N-terminal Pro-brain Natriuretic Peptide and Myocardial Perfusion in Asymptomatic Adults (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol. 2015 May 15; 115(10):1341-5. PMID: 25816778.
      View in: PubMed
    39. Sharma RK, Donekal S, Rosen BD, Tattersall MC, Volpe GJ, Ambale-Venkatesh B, Nasir K, Wu CO, Polak JF, Korcarz CE, Stein JH, Carr J, Watson KE, Bluemke DA, Lima JA. Association of subclinical atherosclerosis using carotid intima-media thickness, carotid plaque, and coronary calcium score with left ventricular dyssynchrony: the multi-ethnic Study of Atherosclerosis. Atherosclerosis. 2015 Apr; 239(2):412-8. PMID: 25682041.
      View in: PubMed
    40. Ziaeian B, Dinkler J, Watson K. Implementation of the 2013 American College of Cardiology/American Heart Association Blood Cholesterol Guideline Including Data From the Improved Reduction of Outcomes: Vytorin Efficacy International Trial. Rev Cardiovasc Med. 2015; 16(2):125-30. PMID: 26198559.
      View in: PubMed
    41. Yang EH, Watson KE, Herrmann J. Should vascular effects of newer treatments be addressed more completely? Future Oncol. 2015; 11(14):1995-8. PMID: 26198824.
      View in: PubMed
    42. Chahal H, Bluemke DA, Wu CO, McClelland R, Liu K, Shea SJ, Burke G, Balfour P, Herrington D, Shi P, Post W, Olson J, Watson KE, Folsom AR, Lima JA. Heart failure risk prediction in the Multi-Ethnic Study of Atherosclerosis. Heart. 2015 Jan; 101(1):58-64. PMID: 25381326.
      View in: PubMed
    43. Dinkler J, Watson K. Practical Implementation of the 2013 AHA/ACC Blood Cholesterol Guidelines. Curr Treat Options Cardiovasc Med. 2014 Nov; 16(11):347. PMID: 25212817.
      View in: PubMed
    44. Soverow J, Watson K. Is there sufficient enhancement of the reduction in CVD rates after a decade of statin therapy to justify continuation? Curr Atheroscler Rep. 2014 Aug; 16(8):432. PMID: 24899387.
      View in: PubMed
    45. Ebong IA, Watson KE, Goff DC, Bluemke DA, Srikanthan P, Horwich T, Bertoni AG. Age at menopause and incident heart failure: the Multi-Ethnic Study of Atherosclerosis. Menopause. 2014 Jun; 21(6):585-91. PMID: 24423934.
      View in: PubMed
    46. Criqui MH, Denenberg JO, McClelland RL, Allison MA, Ix JH, Guerci A, Cohoon KP, Srikanthan P, Watson KE, Wong ND. Abdominal aortic calcium, coronary artery calcium, and cardiovascular morbidity and mortality in the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2014 07; 34(7):1574-9. PMID: 24812323.
      View in: PubMed
    47. Rifkin DE, Khaki AR, Jenny NS, McClelland RL, Budoff M, Watson K, Ix JH, Allison MA. Association of renin and aldosterone with ethnicity and blood pressure: the Multi-Ethnic Study of Atherosclerosis. Am J Hypertens. 2014 Jun; 27(6):801-10. PMID: 24436325.
      View in: PubMed
    48. McMahon M, Skaggs BJ, Grossman JM, Sahakian L, Fitzgerald J, Wong WK, Lourenco EV, Ragavendra N, Charles-Schoeman C, Gorn A, Karpouzas GA, Taylor MB, Watson KE, Weisman MH, Wallace DJ, Hahn BH. A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheumatol. 2014 Jan; 66(1):130-9. PMID: 24449580.
      View in: PubMed
    49. Watson KE, Stocker EH, Jacoby DS, McCullough PA. Advanced lipid testing: when, why, and in whom? Rev Cardiovasc Med. 2014; 15(4):310-7; quiz 318-9. PMID: 25662925.
      View in: PubMed
    50. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC, Tomaselli GF. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 24; 129(25 Suppl 2):S1-45. PMID: 24222016.
      View in: PubMed
    51. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC, Watson K, Wilson PW. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Jul 01; 63(25 Pt B):2889-934. PMID: 24239923.
      View in: PubMed
    52. Sallam T, Watson KE. Predictors of cardiovascular risk in women. Womens Health (Lond). 2013 Sep; 9(5):491-8. PMID: 24007254.
      View in: PubMed
    53. Adar SD, Sheppard L, Vedal S, Polak JF, Sampson PD, Diez Roux AV, Budoff M, Jacobs DR, Barr RG, Watson K, Kaufman JD. Fine particulate air pollution and the progression of carotid intima-medial thickness: a prospective cohort study from the multi-ethnic study of atherosclerosis and air pollution. PLoS Med. 2013; 10(4):e1001430. PMID: 23637576.
      View in: PubMed
    54. Kim C, Diez-Roux AV, Nettleton JA, Polak JF, Post WS, Siscovick DS, Watson KE, Vahratian AM. Sex differences in subclinical atherosclerosis by race/ethnicity in the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2011 Jul 15; 174(2):165-72. PMID: 21685409.
      View in: PubMed
    55. Mitchell JE, Ferdinand KC, Watson KE, Wenger NK, Watkins LO, Flack JM, Gavin JR, Reed JW, Saunders E, Wright JT. Treatment of heart failure in African Americans--a call to action. J Natl Med Assoc. 2011 Feb; 103(2):86-98. PMID: 21443060.
      View in: PubMed
    56. Sanchez DR, Diez Roux AV, Michos ED, Blumenthal RS, Schreiner PJ, Burke GL, Watson K. Comparison of the racial/ethnic prevalence of regular aspirin use for the primary prevention of coronary heart disease from the multi-ethnic study of atherosclerosis. Am J Cardiol. 2011 Jan; 107(1):41-6. PMID: 21146684.
      View in: PubMed
    57. Jain A, McClelland RL, Polak JF, Shea S, Burke GL, Bild DE, Watson KE, Budoff MJ, Liu K, Post WS, Folsom AR, Lima JA, Bluemke DA. Cardiovascular imaging for assessing cardiovascular risk in asymptomatic men versus women: the multi-ethnic study of atherosclerosis (MESA). Circ Cardiovasc Imaging. 2011 Jan; 4(1):8-15. PMID: 21068189.
      View in: PubMed
    58. Watson KE. Pitavastatin: the newest HMG-CoA reductase inhibitor. Rev Cardiovasc Med. 2010; 11(1):26-32. PMID: 20495513.
      View in: PubMed
    59. Meadows TA, Bhatt DL, Hirsch AT, Creager MA, Califf RM, Ohman EM, Cannon CP, Eagle KA, Alberts MJ, Goto S, Smith SC, Wilson PW, Watson KE, Steg PG. Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registry. Am Heart J. 2009 Dec; 158(6):1038-45. PMID: 19958873.
      View in: PubMed
    60. Ferdinand KC, Flack JM, Saunders E, Victor R, Watson K, Kursun A, Jamieson MJ, Shi H. Amlodipine/Atorvastatin single-pill therapy for blood pressure and lipid goals in African Americans: influence of the metabolic syndrome and type 2 diabetes mellitus. J Clin Hypertens (Greenwich). 2009 Oct; 11(10):585-93. PMID: 19817942.
      View in: PubMed
    61. McMahon M, Grossman J, Skaggs B, Fitzgerald J, Sahakian L, Ragavendra N, Charles-Schoeman C, Watson K, Wong WK, Volkmann E, Chen W, Gorn A, Karpouzas G, Weisman M, Wallace DJ, Hahn BH. Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheum. 2009 Aug; 60(8):2428-37. PMID: 19644959.
      View in: PubMed
    62. Fonarow GC, Deedwania P, Fonseca V, Nesto RW, Watson K, Tarka E, Lukas MA, Madan A, Shabbout M. Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial. J Am Soc Hypertens. 2009 May-Jun; 3(3):210-20. PMID: 20409961.
      View in: PubMed
    63. Watson KE. The JUPITER trial: How will it change clinical practice? Rev Cardiovasc Med. 2009; 10(2):91-6. PMID: 19593321.
      View in: PubMed
    64. Cziraky MJ, Watson KE, Talbert RL. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. J Manag Care Pharm. 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PMID: 19891279.
      View in: PubMed
    65. Folsom AR, Kronmal RA, Detrano RC, O'Leary DH, Bild DE, Bluemke DA, Budoff MJ, Liu K, Shea S, Szklo M, Tracy RP, Watson KE, Burke GL. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med. 2008 Jun 23; 168(12):1333-9. PMID: 18574091.
      View in: PubMed
    66. Burke GL, Bertoni AG, Shea S, Tracy R, Watson KE, Blumenthal RS, Chung H, Carnethon MR. The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arch Intern Med. 2008 May 12; 168(9):928-35. PMID: 18474756.
      View in: PubMed
    67. Watson KE. What is the evidence in favor of low-dose statin therapy in 2008? Curr Atheroscler Rep. 2008 Feb; 10(1):33-8. PMID: 18366983.
      View in: PubMed
    68. Flack JM, Victor R, Watson K, Ferdinand KC, Saunders E, Tarasenko L, Jamieson MJ, Shi H, Bruschi P. Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trial. Mayo Clin Proc. 2008 Jan; 83(1):35-45. PMID: 18174006.
      View in: PubMed
    69. Watson KE. Cardiovascular risk reduction among African Americans: a call to action. J Natl Med Assoc. 2008 Jan; 100(1):18-26. PMID: 18277804.
      View in: PubMed
    70. Watson K, Fung CH, Budoff M. Quality indicators for the care of ischemic heart disease in vulnerable elders. J Am Geriatr Soc. 2007 Oct; 55 Suppl 2:S366-72. PMID: 17910559.
      View in: PubMed
    71. Watson K. Managing cardiometabolic risk: an evolving approach to patient care. Crit Pathw Cardiol. 2007 Mar; 6(1):5-14. PMID: 17667880.
      View in: PubMed
    72. Fonarow GC, Watson KE. New insights into understanding cardiometabolic risk. Introduction. Rev Cardiovasc Med. 2007; 8 Suppl 4:S1-2. PMID: 17934389.
      View in: PubMed
    73. Watson KE. Pathogenesis of CHD: the role of elevated triglycerides. J Am Acad Nurse Pract. 2007; 19(12 Suppl 2):4-6, 13-4. PMID: 18510281.
      View in: PubMed
    74. Watson KE, Ansell BJ, Watson AD, Fonarow GC. HDL function as a target of lipid-modifying therapy. Rev Cardiovasc Med. 2007; 8(1):1-8. PMID: 17401296.
      View in: PubMed
    75. Watson KE. Novel therapies for cardiometabolic risk reduction and implications for clinical practice. Rev Cardiovasc Med. 2007; 8 Suppl 4:S37-42. PMID: 17934393.
      View in: PubMed
    76. Watson K. Surgical risk in patients with metabolic syndrome: focus on lipids and hypertension. Curr Cardiol Rep. 2006 Nov; 8(6):433-8. PMID: 17059795.
      View in: PubMed
    77. Polk DM, Watson K. Hospital discharge treatments after an acute event: evidence for a systems approach to prevention. Coron Artery Dis. 2006 May; 17(3):239-41. PMID: 16728873.
      View in: PubMed
    78. Hall WD, Watkins LO, Wright JT, Wenger NK, Kumanyika SK, Gavin JR, Ferdinand KC, Watson K, Clark LT, Flack JM, Reed JW, Horton EW, Saunders E. The metabolic syndrome: recognition and management. Dis Manag. 2006 Feb; 9(1):16-33. PMID: 16466339.
      View in: PubMed
    79. Watson KE. Lowering levels of lipids and homocysteine. Rev Cardiovasc Med. 2006; 7(4):248-50. PMID: 17224870.
      View in: PubMed
    80. Fonarow GC, Watson KE. Treating to low-density lipoprotein goal: a tool for initiating and optimizing lipid-lowering therapy in patients with atherosclerosis or similar risk. Crit Pathw Cardiol. 2005 Dec; 4(4):174-6. PMID: 18340204.
      View in: PubMed
    81. Ferdinand KC, Clark LT, Watson KE, Neal RC, Brown CD, Kong BW, Barnes BO, Cox WR, Zieve FJ, Isaacsohn J, Ycas J, Sager PT, Gold A. Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial. Am J Cardiol. 2006 Jan 15; 97(2):229-35. PMID: 16442368.
      View in: PubMed
    82. Ansell BJ, Watson KE, Fogelman AM, Navab M, Fonarow GC. High-density lipoprotein function recent advances. J Am Coll Cardiol. 2005 Nov 15; 46(10):1792-8. PMID: 16286161.
      View in: PubMed
    83. Watson K. Guidelines for prevention of CVD in women. J Fam Pract. 2005 Jul; Suppl:7-8. PMID: 16134559.
      View in: PubMed
    84. Mosca L, Merz NB, Blumenthal RS, Cziraky MJ, Fabunmi RP, Sarawate C, Watson KE, Willey VJ, Stanek EJ. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting. Circulation. 2005 Feb 01; 111(4):488-93. PMID: 15687138.
      View in: PubMed
    85. Watson KE, Fonarow GC. The past, present, and future of statin therapy. Rev Cardiovasc Med. 2005; 6(3):129-39. PMID: 16195686.
      View in: PubMed
    86. Watson KE. Novel serum markers for risk prediction in acute coronary syndromes. Rev Cardiovasc Med. 2005; 6(1):59-60. PMID: 15741926.
      View in: PubMed
    87. Ansell BJ, Navab M, Watson KE, Fonarow GC, Fogelman AM. Anti-inflammatory properties of HDL. Rev Endocr Metab Disord. 2004 Dec; 5(4):351-8. PMID: 15486468.
      View in: PubMed
    88. Fonarow GC, Watson KE. High-density lipoprotein cholesterol as a therapeutic target to reduce cardiovascular events. Am Heart J. 2004 Jun; 147(6):939-41. PMID: 15199335.
      View in: PubMed
    89. Watson KE. Cardiovascular disease in African Americans. Introduction. Rev Cardiovasc Med. 2004; 5 Suppl 3:S1-2. PMID: 15303079.
      View in: PubMed
    90. Watson KE, Topol EJ. Pathobiology of atherosclerosis: are there racial and ethnic differences? Rev Cardiovasc Med. 2004; 5 Suppl 3:S14-21. PMID: 15303081.
      View in: PubMed
    91. Watson KE, Fonarow GC. Cardiovascular disease in African Americans. Closing the knowledge, treatment, and outcome gap. Rev Cardiovasc Med. 2004; 5 Suppl 3:S42-4. PMID: 15303085.
      View in: PubMed
    92. Watson KE. The relationship between inflammation and atherosclerotic events. Rev Cardiovasc Med. 2004; 5(1):66-8. PMID: 15085794.
      View in: PubMed
    93. Krantz MJ, Leeman-Castillo BA, Watson KE, Mehler PS. Coronary heart disease care in older women: optimizing diagnostic and therapeutic decisions. J Am Med Womens Assoc (1972). 2004; 59(4):286-94. PMID: 16845758.
      View in: PubMed
    94. Watson KE, Peters Harmel AL, Matson G. Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance. J Cardiovasc Pharmacol Ther. 2003 Dec; 8(4):253-60. PMID: 14740074.
      View in: PubMed
    95. Watson KE. Plasma lipoprotein concentrations in ethnic populations. Curr Cardiol Rep. 2003 Nov; 5(6):483-7. PMID: 14558991.
      View in: PubMed
    96. Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Boström K, Demer LL. Multilineage potential of cells from the artery wall. Circulation. 2003 Nov 18; 108(20):2505-10. PMID: 14581408.
      View in: PubMed
    97. Fonarow GC, Watson KE. Effective strategies for long-term statin use. Am J Cardiol. 2003 Jul 03; 92(1A):27i-34i. PMID: 12867252.
      View in: PubMed
    98. Fonarow GC, Gawlinski A, Watson K. In-hospital initiation of cardiovascular protective therapies to improve treatment rates and clinical outcomes: the University of California-Los Angeles, Cardiovascular Hospitalization Atherosclerosis Management Program. Crit Pathw Cardiol. 2003 Jun; 2(2):61-70. PMID: 18340322.
      View in: PubMed
    99. Hall WD, Clark LT, Wenger NK, Wright JT, Kumanyika SK, Watson K, Horton EW, Flack JM, Ferdinand KC, Gavin JR, Reed JW, Saunders E, O'Neal W. The Metabolic Syndrome in African Americans: a review. Ethn Dis. 2003; 13(4):414-28. PMID: 14632261.
      View in: PubMed
    100. Watson KE, Horowitz BN, Matson G. Lipid abnormalities in insulin resistant states. Rev Cardiovasc Med. 2003; 4(4):228-36. PMID: 14668690.
      View in: PubMed
    101. Ansell BJ, Watson KE, Weiss RE, Fonarow GC. hsCRP and HDL effects of statins trial (CHEST): rapid effect of statin therapy on C-reactive protein and high-density lipoprotein levels A clinical investigation. Heart Dis. 2003 Jan-Feb; 5(1):2-7. PMID: 12549983.
      View in: PubMed
    102. Watson KE, Fonarow GC. Lessons learned from recent lipid-lowering trials: why physicians should change clinical practice. Clin Cornerstone. 2003; Suppl 1:S11-7. PMID: 14699987.
      View in: PubMed
    103. Watson K, Jamerson K. Therapeutic lifestyle changes for hypertension and cardiovascular risk reduction. J Clin Hypertens (Greenwich). 2003 Jan-Feb; 5(1 Suppl 1):32-7. PMID: 12556671.
      View in: PubMed
    104. Hall WD, Clark LT, Wenger NK, Wright JT, Kumanyika SK, Watson K, Horton EW, Flack JM, Ferdinand KC, Gavin JR, Reed JW, Saunders E, O'Neal W. For the patient. What is the Metabolic Syndrome and why is it important? Ethn Dis. 2003; 13(4):546. PMID: 14632275.
      View in: PubMed
    105. Watson K. Lipid lowering in high-risk populations: how low should we go? Ethn Dis. 2001; 11(4):834-7. PMID: 11763308.
      View in: PubMed